ROC curve analysis reveals the power of the relative expression levels of LINC01564, RAMS11, CBX4 and TOP2A in discriminating HCC patients from HCV group, suggesting the possible role of these molecular non-invasive markers in early diagnosis of HCC in chronic hepatitis C cases. This evidence concerns the gene CBX4 and hepatocellular carcinoma.